What the study of a supercentenarian after her death can tell us about our lives By HPN Staff Key Points The researchers emphasize that reaching extreme old age doesn’t inevitably mean persistent chronic disease. In Morera’s case, she had short telomeres (a usual mark... Read more Children’s hospital caught in North Carolina budget battle as lawmakers seek to close funding gaps By HPN Staff Key Points North Carolina’s House and Senate remain divided on Medicaid funding levels ($500M vs. $640M plus admin costs) and whether to tie funding to a new UNC-Duke children... Read more Why the Trump Administration is delaying limits on some ‘forever chemicals’ By HPN Staff Key Points The Trump EPA pushed back implementation of Biden-era drinking-water limits for PFOS and PFOA from 2029 to 2031 and rolled back limits on four other PFAS chemicals.... Read more Acupuncture shows promise for back pain in older adults, study finds By HPN Staff Key Points In an 800-participant trial of adults 65+, acupuncture for chronic lower back pain produced modest but positive and sustained improvements in pain and function, com... Read more New evidence links microplastics to degenerative disease By HPN Staff Key Points A University of Rhode Island study found that microplastic exposure in mice with the APOE4 gene triggered Alzheimer’s-like symptoms, with ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5 MOST VIEWED 1 Rural training is an effective workforce strategy 2 Wisconsin joins 48 other states to improve postpartum health care coverage 3 A move is underway to expand doctor supply by cutting licensing barriers 4 Florida Senate approves Medicaid work requirements DONATE
Children’s hospital caught in North Carolina budget battle as lawmakers seek to close funding gaps By HPN Staff Key Points North Carolina’s House and Senate remain divided on Medicaid funding levels ($500M vs. $640M plus admin costs) and whether to tie funding to a new UNC-Duke children... Read more Why the Trump Administration is delaying limits on some ‘forever chemicals’ By HPN Staff Key Points The Trump EPA pushed back implementation of Biden-era drinking-water limits for PFOS and PFOA from 2029 to 2031 and rolled back limits on four other PFAS chemicals.... Read more Acupuncture shows promise for back pain in older adults, study finds By HPN Staff Key Points In an 800-participant trial of adults 65+, acupuncture for chronic lower back pain produced modest but positive and sustained improvements in pain and function, com... Read more New evidence links microplastics to degenerative disease By HPN Staff Key Points A University of Rhode Island study found that microplastic exposure in mice with the APOE4 gene triggered Alzheimer’s-like symptoms, with ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
Why the Trump Administration is delaying limits on some ‘forever chemicals’ By HPN Staff Key Points The Trump EPA pushed back implementation of Biden-era drinking-water limits for PFOS and PFOA from 2029 to 2031 and rolled back limits on four other PFAS chemicals.... Read more Acupuncture shows promise for back pain in older adults, study finds By HPN Staff Key Points In an 800-participant trial of adults 65+, acupuncture for chronic lower back pain produced modest but positive and sustained improvements in pain and function, com... Read more New evidence links microplastics to degenerative disease By HPN Staff Key Points A University of Rhode Island study found that microplastic exposure in mice with the APOE4 gene triggered Alzheimer’s-like symptoms, with ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
Acupuncture shows promise for back pain in older adults, study finds By HPN Staff Key Points In an 800-participant trial of adults 65+, acupuncture for chronic lower back pain produced modest but positive and sustained improvements in pain and function, com... Read more New evidence links microplastics to degenerative disease By HPN Staff Key Points A University of Rhode Island study found that microplastic exposure in mice with the APOE4 gene triggered Alzheimer’s-like symptoms, with ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
New evidence links microplastics to degenerative disease By HPN Staff Key Points A University of Rhode Island study found that microplastic exposure in mice with the APOE4 gene triggered Alzheimer’s-like symptoms, with ... Read more Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
Facing backlash, health insurers to curb use of prior authorization By HPN Staff Key Points U.S. health insurers, under pressure from policymakers, will scale back prior authorization requirements by 2026, easing delays that frustrate... Read more Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
Critics call for transparency in a federal hospital funding stream By HPN Staff Key Points The federal 340B program, originally designed to help safety-net hospitals fund uncompensated care, has grown dramatically and now faces scrut... Read more Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
Stem cell therapy shows promise in treating lifelong disease By HPN Staff Key Points In a trial of 12 patients with type 1 diabetes, 10 were cured and 2 saw major improvement using the stem cell therapy Zimislecel. T... Read more New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more 1 2 3 4 5
New blood test offers early detection of neurodegenerative disorder By HPN Staff The Food and Drug Administration (FDA) recently approved a new tool in the fight against Alzheimer’s disease — a blood test that detects plaques known to be... Read more Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more
Telehealth appointments can boost impact of weight-loss drugs, study finds By HPN Staff Regular telehealth appointments for obesity patients could significantly improve the effectiveness of weight-loss drugs like Ozempic and Wegovy, which are o... Read more
